Deep Breaths: Updates from CHEST

Host: Stephanie Christenson, MD Guest: Diego Maselli, MD, FCCP COPD is increasingly recognized as a heterogeneous disease, and for a subset of patients, type 2 inflammation plays a meaningful role in exacerbation risk and treatment response. Given that, Drs. Stephanie Christenson and Diego Maselli come together to examine how insights into the pathobiology of type 2 inflammation can directly infor...

Guest: Ravi Kalhan, MD Guest: MeiLan K. Han, MD, MS For patients with chronic obstructive pulmonary disease (COPD), exacerbations are early indicators of disease progression—not just isolated events. In this expert-led discussion, Drs. Ravi Kalhan and Meilan Han break down the latest GOLD updates, explain how to use eosinophil counts to guide treatment, and discuss when to consider adding biologic...

Host: Gerard A. Silvestri MD, MS, Master FCCP Guest: Anurag Singh, MD Guest: Adam H. Fox, MD, MSc Guest: Mariam Alexander, MD, PhD Despite the typically poor prognosis of extensive-stage small cell lung cancer, recent advancements are reshaping clinical perspectives on treatment. New and emerging options show promise for prolonged survival and improved quality of life. Join Drs. Gerard Silvestri,...

Host: Diego Maselli, MD Guest: Monica Kraft, MD, FCCP Guest: Anju T Peters, MD, MSCI, FAAAAI IL-5 is a key driver of Type 2 inflammation in patients with severe asthma, promoting downstream effects like mucus plugging and epithelial barrier dysfunction. Given these impacts, targeted therapy with biologics can play a role in severe asthma management. Join Drs. Diego Maselli, Anju Peters, and Monica...

Host: Nathan Falk, MD, MBA, FAAFP Guest: Megan Conroy, MD, MA(Ed), FCCP Patients with chronic obstructive pulmonary disease (COPD) often experience significant delays in diagnosis and treatment due to systemic gaps in management. A recent survey of 400 primary care and pulmonary clinicians uncovered patterns of fragmented care among both specialties. Join Dr. Nate Falk and Dr. Megan Conroy as they...

Host: Angela Birdwell, DO, MA, FCCP Guest: Antonio Anzueto, MD Guest: Susan Corbridge, PhD, APRN, ACNP-BC, FAANP, FCCP, FAAN Although the prevalence of chronic obstructive pulmonary disease (COPD) has decreased in adults aged 18 to 44, it remains elevated in certain patient groups, like women, adults over 65, smokers, and those living in rural areas. This prevalence emphasizes the importance of a...

Guest: Ashwin Basavaraj, MD Host: Christopher Lippincott, MD, MPH From airway clearance techniques and mucoactive therapy—what can clinicians do to manage bronchiectasis exacerbations? To answer this question, Dr. Christopher Lippincott and Dr. Ashwin Basavaraj explore the mechanisms that lead to bronchiectasis and share strategies to manage exacerbations. This program is produced in partnership w...

Host: Ashwin Basavaraj, MD Guest: Christopher Lippincott, MD, MPH Bronchiectasis is a complex syndrome that can lead to an interconnected cascade of airway dysfunction and inflammation. How has our understanding of this syndrome evolved with Cole’s vicious cycle hypothesis? Dr. Ashwin Basavaraj and Dr. Christopher Lippincott take a closer look at this hypothesis and the clinical mechanisms behind...

Host: Stephanie Christenson, MD Guest: Ron Balkissoon, MD, MSc, DIH, FRCPC What do we need to know about the pathophysiology and burden of COPD exacerbations? To better understand this—and the factors that may put our patients at risk—Dr. Stephanie Christenson from the University of California San Francisco and Dr. Ron Balkissoon from National Jewish Health share insights on COPD exacerbations. Th...

Host: Stephanie Christenson, MD Guest: Ron Balkissoon, MD, MSc, DIH, FRCPC What is a COPD exacerbation, and what puts our patients at risk of them? Drs. Stephanie Christenson and Ron Balkissoon discuss these risks and the burden of COPD exacerbations on our patients. This is a non-promotional, non-CME disease state educational program brought to you by CHEST in collaboration with and sponsored by...

Host: Randy Young, MD Guest: Daniel Jay Feinstein, MD, FACP, MS, ACRP-PI Diagnosing pneumonia can be challenging, but the CAP guidelines offer recommendations to improve the detection of this infection. To find out more about the recommendations, Dr. Randy Young and Dr. Daniel Feinstein, a Physician Executive at Novant Health, dive into testing for pneumonia. This is a non-promotional, non-CME dis...

Host: Randy Young, MD Guest: Tufik Assad, MD, MSCI What are the factors that make diagnosing pneumonia challenging, and how might emerging testing modalities improve that? To answer this question, Dr. Randy Young and Dr. Tufik Assad from the Williamson Medical Center in Franklin, Tennessee dive into the etiology, diagnostic challenges, and current trends in pneumonia diagnostics. This is a non-pro...

Host: Frank C. Sciurba, MD, FCCP Guest: Emily L. Yee, MD What do we need to know about using endobronchial valves in patients with severe COPD and emphysema? Drs. Frank Sciurba and Emily Yee explore the impact of these valves on patients. This educational podcast is produced in partnership with the American College of CHEST Physicians and sponsored by Pulmonx Corporation, the manufacturer of Zephy...

Host: Ashwin Basavaraj, MD Nontuberculous mycobacteria (NTM) and bronchiectasis are challenging diseases that require a multidisciplinary approach to treat. Dr. Ashwin Basavaraj sits down with his patient, Mary, to learn more about these obstacles and discuss how we can find the right care team. This program is produced in partnership with the American College of CHEST Physicians, and is sponsored...

Host: Doreen Addrizzo-Harris, MD Guest: Ashwin Basavaraj, MD From evaluating diagnostic criteria to nonpharmacologic therapy, what do the NTM guidelines recommend when it comes to the treatment of MAC lung disease? Drs. Doreen Addrizzo-Harris and Ashwin Basavaraj from NYU Grossman School of Medicine will dive into the practical application of the NTM guidelines. This program is produced in partner...

Host: David Schulman, MD, MPH, FCCP Guest: Andrew H. Limper, MD Guest: Timothy A. Hernandez, MD There are many barriers to reaching a definitive diagnosis for idiopathic pulmonary fibrosis (IPF). To learn more about these obstacles—and how we can overcome them—Dr. David Schulman from the American College of Chest Physicians joins Dr. Tim Hernandez from the University of Texas Health Sciences Cente...

Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Kathleen M. Buchheit, MD Guest: Philippe Gevaert, MD, PhD Do cytokines play a role in chronic rhinosinusitis? Dr. Peter Howarth is joined by Dr. Katie Buchheit, an Associate Professor of Medicine at Harvard Medical School, and Professor Philippe Gevaert, an ENT specialist at the Department of Otorhinolaryngology at Ghent University and the Upp...

Host: Peter Howarth BSc, (Hons), MBBS, DM, FRCP Guest: Ian Pavord, MA, DM, FRCP, FERS, FMedSci Guest: Geoffrey Chupp, MD Type 2 inflammation can be challenging to identify. What should we be looking for in our patients with severe asthma and COPD? Joining Dr. Peter Howarth to discuss identifying this type of inflammation are Dr. Geoffrey Chupp from the Yale School of Medicine and Dr. Ian Pavord fr...

Host: Muhammad Adrish MD, MBA, FCCP, FCCM Guest: Navitha Ramesh, MD, FCCP Inhalers are one of the most common methods of delivery for the treatment of COPD, but is it the best option for all of our patients? Associate Professor of Pulmonary Critical Care at Baylor College of Medicine, Dr. Muhammad Adrish, reviews LAMA use for COPD patients with Dr. Navitha Ramesh, Assistant Professor at Drexel Uni...

Host: Megan Conroy, MD, MA(Ed), FCCP Guest: Farrukh Abbas, MD On average, more than two-thirds of patients with chronic obstructive pulmonary disease (COPD) make at least one error in using an inhaler device. Fortunately, nebulized long-acting muscarinic antagonists (LAMAs) can help our patients overcome this common challenge in COPD care. That’s why Drs. Megan Conroy and Farrukh Abbas come togeth...

Guest: Jared Nathan Silver, MD, PhD Guest: Praveen Akuthota, MD Eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndromes are often mistaken for each other. How can we better distinguish these diseases? Dr. Jared Silver discusses how to diagnose these diseases with Dr. Praveen Akuthota, a pulmonologist from U.C. San Diego Medical Center in California. This is a non-promotional,...

Host: Tom Corbridge, MD, FCCP Guest: Michael E. Wechsler, MD, MMSc Severe asthma is an uncontrolled disease that can be difficult to diagnose. To help us overcome this obstacle, Dr. Tom Corbridge joins Dr. Michael Wechsler from National Jewish Health in Denver to discuss the challenges we face while trying to diagnose severe asthma. This is a non-promotional, non-CME disease state disease educatio...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Hassan Bencheqroun, MD Evaluating the need for therapy escalation can be challenging. So joining Dr. Charles Turck to help us understand how to escalate treatment for patients with chronic obstructive pulmonary disease is Dr. Hassan Bencheqroun, Assistant Professor of Medicine at the University of California Riverside School of Medicine. This is a no...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Deborah Levine, MD, FCCP To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health. This is a non-promotional, non-CME disease state...

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Chitra Lal, MD Dr. Charles Turck is joined by Dr. Chitra Lal, a Professor of Medicine at the Medical University of South Carolina in Charleston, to share strategies for adherence to treatment and discuss multiple versus single inhaler triple therapy for COPD. This is a non-promotional, non-CME disease state disease education podcast series brought to...